Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omission of lateral lymph node dissection in medullary thyroid cancer without a desmoplastic stromal reaction
Martin B. Niederle, Philipp Riss, Andreas Selberherr, et al.
British journal of surgery (2020) Vol. 108, Iss. 2, pp. 174-181
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept
Martin B. Niederle, Teresa Binter, Philipp Riss, et al.
Annals of Surgical Oncology (2025)
Open Access | Times Cited: 1
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3643-3643
Open Access | Times Cited: 34
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
Linnea Højer Wang, Markus Wehland, Petra M. Wise, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2312-2312
Open Access | Times Cited: 22
Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy
Henning Dralle, Tim Brandenburg, Frank Weber, et al.
Surgery (2023) Vol. 174, Iss. 6, pp. 1356-1362
Closed Access | Times Cited: 22
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?
Teresa Binter, Sabina Baumgartner‐Parzer, Marie Helene Schernthaner-Reiter, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 494-494
Open Access | Times Cited: 8
Latest Progress in Risk-Adapted Surgery for Medullary Thyroid Cancer
Andreas Machens, Kerstin Lorenz, Tim Brandenburg, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 917-917
Open Access | Times Cited: 7
Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules
Martina Broecker‐Preuss, Dietmar Simon, Mirka Fries, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2333-2333
Open Access | Times Cited: 12
The Value of Pretherapeutic Basal Calcitonin Cut-Offs for the Therapeutic Strategy and Prediction of Long-Term Outcome of Patients with Medullary Thyroid Cancer—A 30-Year Single-Center Experience
Martin B. Niederle, Teresa Binter, Philipp Riss, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3343-3343
Open Access | Times Cited: 4
Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
Priscilla Francesca Procopio, Francesco Pennestrì, Nikolaos Voloudakis, et al.
Surgery (2024), pp. 108881-108881
Closed Access | Times Cited: 4
Diagnostic value of preoperative systemic inflammatory markers and carcinoembryonic antigen in medullary thyroid carcinoma and the risk factors affecting its prognosis
Zhujuan Wu, Yuhan Jiang, Hao Gong, et al.
Gland Surgery (2025) Vol. 14, Iss. 1, pp. 13-27
Open Access
ASO Author Reflections: Combining Two Easily Available Parameters Can Help to Individualize Lymph Node Surgery in Medullary Thyroid Cancer (MTC) Without Compromising Cure Rates
Martin B. Niederle, Teresa Binter, Philipp Riss, et al.
Annals of Surgical Oncology (2025)
Open Access
Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma
Friedhelm Raue, Karin Frank‐Raue
Recent results in cancer research/Recent Results in Cancer Research (2025), pp. 93-127
Closed Access
What Is New in Diagnostics and Management of Medullary Thyroid Carcinoma
Friedhelm Raue, Karin Frank‐Raue
Recent results in cancer research/Recent Results in Cancer Research (2025), pp. 1-8
Closed Access
Bedeutung des Schnellschnittes in der endokrinen Tumorchirurgie
Costanza Chiapponi, Atsuko Kasajima
Deleted Journal (2025)
Closed Access
Invited Editorial About: Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept
Gabriela L. Aitken, Olivia M. DeLozier, Paxton V. Dickson
Annals of Surgical Oncology (2025)
Closed Access
Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer
Andreas Machens, Peter Kaatzsch, Kerstin Lorenz, et al.
Surgery (2021) Vol. 171, Iss. 2, pp. 360-367
Closed Access | Times Cited: 26
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
Marisa A. Bartz-Kurycki, Omowunmi E. Oluwo, Lilah F. Morris
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 25
Individualization of treatment in sporadic and hereditary medullary thyroid cancer
Kerstin Lorenz, Andreas Machens, Henning Dralle
Deleted Journal (2024) Vol. 95, Iss. 3, pp. 186-191
Closed Access | Times Cited: 2
Desmoplastic reaction in medullary thyroid carcinoma predicts presence of lymph node metastasis
Joaquín Gómez-Ramirez, Patricia Luengo, Enrique Mercader, et al.
British journal of surgery (2023) Vol. 110, Iss. 8, pp. 1011-1012
Open Access | Times Cited: 6
Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old
Binfeng Yang, Guangcai Niu, Xiaoxin Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 9
Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade
Ignacio Ruz‐Caracuel, Tamara Caniego-Casas, Teresa Alonso‐Gordoa, et al.
Endocrine Pathology (2024) Vol. 35, Iss. 3, pp. 207-218
Open Access | Times Cited: 1
How I treat medullary thyroid cancer
Barbara Kiesewetter, Philipp Riss, Christian Scheuba, et al.
ESMO Open (2021) Vol. 6, Iss. 3, pp. 100183-100183
Open Access | Times Cited: 9
Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer‐specific survival in medullary thyroid cancer
Andreas Machens, Kerstin Lorenz, Frank Weber, et al.
Head & Neck (2022) Vol. 44, Iss. 12, pp. 2717-2726
Closed Access | Times Cited: 6
Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature
Andrea Contarino, Alessia Dolci, Marco Maggioni, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 5
Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study
Guiming Fu, Xiaoyi Li, Fengli Guo, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top